{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(23)"],"submitter":["Sun LY"],"pubmed_abstract":["<h4>Email</h4>zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com.<h4>Background</h4>Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice.<h4>Methods</h4>Clinical data of patients who underwent hepatectomy for HCC at 8 "],"journal":["Annals of translational medicine"],"pagination":["1591"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7791207"],"repository":["biostudies-literature"],"pubmed_title":["A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma."],"pmcid":["PMC7791207"],"pubmed_authors":["Diao YK","Zhou YH","Li J","Sun LY","Li C","Zhu H","Pawlik TM","Shen F","Gu WM","Xing H","Liang L","Zeng YY","Yang T","Chen TH","Zhang CW","Lau WY"],"additional_accession":[]},"is_claimable":false,"name":"A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.","description":"<h4>Email</h4>zhangchengwuzr@hotmail.com; Prof. Tian Yang, MD. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China. Email: yangtiandfgd@hotmail.com.<h4>Background</h4>Identifying patients at high risks of developing postoperative morbidity is important to improve perioperative outcomes. We sought to define the accuracy of two objective and non-invasive serological-based scores, i.e., albumin-bilirubin (ALBI) and aspartate transaminase-to-platelet ratio index (APRI), to predict postoperative morbidity among patients undergoing hepatectomy for hepatocellular carcinoma (HCC), and build up a personalized predictive tool for clinical practice.<h4>Methods</h4>Clinical data of patients who underwent hepatectomy for HCC at 8 ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2025-04-05T16:11:24.339Z","creation":"2025-04-05T16:11:24.339Z"},"accession":"S-EPMC7791207","cross_references":{"pubmed":["33437790"],"doi":["10.21037/atm-20-1421"]}}